ArticleJournal of autoimmunity2013

Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.

Atsushi Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.